Investigational products and the disclaimer modal

Some peptides — retatrutide is the canonical example — are investigational compounds without FDA approval for general clinical use. We gate those SKUs behind a one-time disclaimer.

Three statements you confirm:

Not FDA-approved for general clinical use — Statements about the product haven't been evaluated by the FDA.
For licensed-practitioner or qualified-research use only — The clinical determination is yours, not ours.
State restrictions and chain of custody — Checkout will block restricted destinations; once the package leaves us, the chain of custody is yours.

You tick the attestation checkbox and click Confirm and continue. The product drops into your cart and we log a timestamped record of your confirmation.

Why we log it

The attestation record is the legal artifact — if a regulator ever asks for proof that the practitioner acknowledged the investigational status of the product, the record is exportable from your order history. Retention: seven years from the order date.

See the Compliance posture §02 for the full framing.